Digital Health Deals Sparked in 2016
Virtually every aspect of the healthcare industry now relies on some form of technology or data to improve patient outcomes, reduce costs or readmissions, or to analyze masses of population health data in order to manage that population better. Even more pressing in 2017 is the need to secure all that data and technology. But that hasn’t slowed the pace of M&A one bit. Mergers and acquisitions in the digital health sector soared 23% in 2016, to 155 transactions, compared with 126 deals in 2015. Even more impressive, the sector posted its highest dollar volume ever, nearly $20.2 billion—a 226% increase versus 2015. However, a single mega-merger accounted for 64% of 2016’s dollar... Read More »Q2:16 Results Defy Brexit and Other Uncertainties
You’ve seen the headlines: Global mergers and acquisitions slid in the first half of 2016, as did the combined value. The number of middle market deals completed in the second quarter fell to levels not seen since 2009. Buyers are walking away from targets that could be affected by sudden changes in tax regulations. It’s all thanks to Brexit and the U.S. presidential election. Then there’s the healthcare market. Deal volume actually increased compared with the previous quarter in 2016, and the same quarter a year ago. Deal volume for Q2:16 reached 396 announced transactions, up 11% versus Q1:16’s 358 deals, and 15% higher than last year’s 344 deals in the second quarter. For the first half... Read More »MEDNAX’ MedData Adds RCM Company
MedData, Inc. made its second acquisition this year. The MEDNAX (NYSE: MD) subsidiary agreed to pay $400 million for revenue cycle management (RCM) company Cardon Outreach LLC, a portfolio company of Serent Capital. Cardon Outreach provides specialized eligibility assistance, accounts receivable recovery services, third-party liability and other services. Cardon Outreach works with more than 800 hospitals and other healthcare facilities in 46 states. The acquisition is expected to be accretive to GAAP earnings. MEDNAX anticipates the acquisition will add an initial $0.06 in annualized diluted earnings per share and $0.14 in annualized adjusted earnings per share. Cain Brothers is... Read More »MEDNAX Looks to Improve the Patient Experience
MEDNAX , Inc. (NYSE: MD), once focused exclusively on managing neonatology and anesthesia practices, is moving to manage the entire patient experience. In August 2014, it acquired MedData, Inc., a revenue cycle management company for an undisclosed price. The plan was to provide management services to facilities and physician groups beyond its then-existing footprint. A year later, in September 2015, MedData brought aboard Alegis Revenue Group, a national third-party receivables company. Alegis managed more than $3 billion in charges for more than 240 hospitals nationwide. The company’s patient-advocacy approach to eligibility and enrollment cut revenue cycle time from referral to... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
